In October 2024, Topas Therapeutics announced positive topline results from its Phase IIa trial of TPM502, in patients with celiac disease. The study data serves as the first clinical proof of concept ...
Since launching the first PowerSoul Cafe in March 2024, Dina Mitchell, founder of the world’s first certified gluten-free fast-food restaurant chain made her goals known: to fill a true void in quick ...
Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the data ...